Elsevier Announces New Journal Partnership for 2008
Official Affiliation of the International Society for the Study of Fatty Acids and Lipids to Prostaglandins, Leukotrienes & Essential Fatty Acids
Oxford, UK, 6 December 2007 – Elsevier is pleased to announce that in 2008 the leading fatty-acid research journal Prostaglandins, Leukotrienes & Essential Fatty Acids (PLEFA) will become the Official Journal of the International Society for the Study of Fatty Acids and Lipids (ISSFAL).
2008 also marks the journal’s 30th Anniversary. PLEFA was founded in 1978 as Prostaglandins and Medicine by the late David F Horrobin, and published by Churchill Livingstone. PLEFA addresses all aspects of the roles of lipids and their metabolites in cellular, organ and whole-organism function, and places a particular emphasis on human studies. The relevance of this research, including into omega-3 fatty acids, to the development of novel treatments for disease is growing.
Current Editor-in-Chief Mehar S Manku comments, “The affiliation of ISSFAL to PLEFA is an important step in both the journal and society’s growth and maturity. We warmly welcome ISSFAL members to PLEFA. Many ISSFAL members have previous experience of publication in PLEFA and therefore the association between the parties seems a natural one. We will work together to better understand the role of fatty acids and their several important bioactive metabolites in health and disease. Our common aim is to make PLEFA the leading journal in this field.”
In addition, “There is no doubt that in science, communication is crucial. ISSFAL has become the recognised scientific society in the field of lipids in nutrition, and as such needs a recognised medium to facilitate that communication. PLEFA is a key journal in this field, and so a link is logical between the two. ISSFAL is therefore pleased to make PLEFA the Official Journal of the Society. I wish every success for this promising joint venture,” states Michel Lagarde, President of ISSFAL.
In 2008, all members of ISSFAL will have full online access to PLEFA, including its 30-year archive, online via a new site: www.PLEFA.com
# # #
The role of lipids, including essential fatty acids and their prostaglandin, leukotriene and other derivatives, is now evident in almost all areas of biomedical science. Cell membrane behaviour and cell signalling in all tissues are highly dependent on the lipid constituents of cells. Prostaglandins, Leukotrienes & Essential Fatty Acids aims to cover all aspects of the roles of lipids in cellular, organ and whole organism function, and places a particular emphasis on human studies. Papers concerning all medical specialties are published. Much of the material is particularly relevant to the development of novel treatments for disease. PLEFA is Medline indexed, and has an Impact Factor of 2.261 (Journal Citation Reports ® 2007, Published by Thomson Scientific).
ISSFAL is an International Scientific Society established in 1991, of more than 500 members from more than 40 countries. ISSFAL members are scientists, medical professionals, educators, administrators, communicators and others with an interest in the health effects of dietary fats, oils and lipids; members include researchers carrying out studies on the health effects of omega-3 and omega-6 fatty acids, conjugated linoleic acids, saturated and monounsaturated fatty acids as well as other lipids. ISSFAL is the foremost International Scientific Society dealing exclusively with the health impact of dietary lipids.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media Contact:
Andrew Miller, PhD
+44 (0) 1865 8438 23